June 13, 2019
Joint Commission evaluating revisions to USP General Chapter <797>
Editor's Note
The Joint Commission on June 12 announced that it is reviewing the United States Pharmacopeial Convention (USP) revisions to its General Chapter <797> Pharmaceutical Compounding−Sterile Preparations.
The Joint Commission is evaluating the effect of the revisions on its accredited organizations and plans to issue guidance and updated survey information in the coming months.
Affected organizations will have to meet the new requirements by December 1, 2019.
Free Daily News
- Kentucky Derby, SPD race: Leadership lessons energized SPD professionals at HSPA 2025
- Continuum-based protocol offers new strategy for preventing PONV after thyroidectomy
- Pembrolizumab sets new standard in advanced head and neck cancer surgery, trial shows
- Subarachnoid spinal anesthesia offers safe, effective option for high-risk obstetric patients
- Same-day discharge after catheter ablation gains backing from top cardiology societies
- Tenet, HCA post strong Q1 results, but caution looms over policy uncertainty, outpatient trends
- Telemedicine transforms postoperative care through safer, faster, patient-centered recovery
- ASCA conference coverage to keep ASC leaders informed
- Study: Prolonged COVID symptoms more likely for healthcare workers
- Study: Patients of female surgeons experience fewer complications, lower long-term readmission
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement